Tag: Research
-
Metformin May Prevent Long COVID, Trial Finds
Metformin, a drug commonly used to treat diabetes, may prevent the development of “long COVID,” according to a clinical trial published in The Lancet Infectious Diseases.
-
Immunotherapy Improves Remission for Relapsed, Refractory Leukemia
A single infusion of CAR T-cell therapy induced complete response or remission in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, according to a recent clinical trial published in The Lancet.
-
Broad-Spectrum Antibiotics Decrease Infection Rates in Pancreas Surgery
Administering broad-spectrum antibiotics before surgery to remove pancreas tumors may decrease the chances of surgical site infection, according to a recent study published in JAMA.
-
More Green Spaces Linked to Slower Biological Aging
Living near to green spaces were associated with slower biological aging, according to a Northwestern Medicine study published in Science Advances.
-
Using Physiology to Predict Treatment Response in Eosinophilic Esophagitis
Northwestern Medicine scientists have identified and characterized common symptoms and patterns in Eosinophilic esophagitis, according to a study published in the journal Gastroenterology, findings that will help predict how patients will respond to treatment.
-
Designing Surfaces to Improve Bone Grafts
New research from Northwestern investigators has demonstrated a method for engineering bone surfaces to improve the quality of bone grafts.
-
Study Identifies Mechanisms Driving Immune Cell Recruitment During Inflammation
Northwestern Medicine investigators have discovered a novel mechanism that regulates neutrophil recruitment into tissue during inflammation, which could be targeted to treat different inflammatory diseases and conditions, according to a recent study published in the Journal of Clinical Investigation.
-
Checkpoint Inhibitor Plus Chemotherapy Improves Outcomes for Hodgkin Lymphoma
Adding a checkpoint inhibitor to conventional chemotherapy improved outcomes for patients with relapsed or refractory classic Hodgkin lymphoma, according to a Northwestern Medicine phase II clinical trial published in JAMA Oncology.
-
New Leadership in the Department of Medicine
Douglas E. Vaughan, MD, has announced his intention to step down as chair of The Department of Medicine, effective September 1; Susan Quaggin, MD, has been named as his successor.
-
Combining Epigenetic and Metabolic Approaches for Targeted Cancer Treatment
Northwestern Medicine scientists have identified a novel vulnerability in a subset of genes commonly mutated in cancer, according to a study recently published in The Journal of Clinical Investigation.
